Medications for Pathology
128 results
Aciphex (rabeprazole sodium)
(rabeprazole sodium)Physicians Total Care, Inc.
Usage: ACIPHEX is indicated for healing and symptomatic relief of erosive or ulcerative GERD, maintenance of GERD healing, treatment of GERD symptoms in adults and adolescents, healing of duodenal ulcers, H. pylori eradication to reduce ulcer recurrence, and long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome.
Aciphex (rabeprazole sodium)
(rabeprazole sodium)Woodward Pharma Services LLC
Usage: ACIPHEX delayed-release tablets are indicated for the healing and maintenance of erosive or ulcerative GERD, treatment of symptomatic GERD in adults and adolescents, healing of duodenal ulcers, H. pylori eradication to prevent ulcer recurrence, and long-term management of pathological hypersecretory conditions, including Zollinger-Ellison syndrome.
Aciphex (rabeprazole sodium)
(rabeprazole sodium)Waylis Therapeutics LLC
Usage: ACIPHEX is indicated for the short-term treatment of erosive or ulcerative GERD in adults, maintenance of healing, symptomatic relief of GERD, healing of duodenal ulcers, eradication of H. pylori, treatment of pathological hypersecretory conditions, and symptomatic GERD in adolescents aged 12 and older for up to 8 weeks.
Cimetidine (cimetidine)
(cimetidine)Northwind Pharmaceuticals
Usage: Cimetidine tablets are indicated for the short-term treatment of active duodenal and benign gastric ulcers, maintenance therapy post-healing, erosive gastroesophageal reflux disease (GERD), and pathological hypersecretory conditions such as Zollinger-Ellison Syndrome. Treatment durations typically do not exceed established limits unless specified.
Cimetidine (cimetidine)
(Cimetidine)Denton Pharma, Inc. DBA Northwind Pharmaceuticals
Usage: Cimetidine tablets are indicated for the short-term treatment of active duodenal and benign gastric ulcers, maintenance therapy for healed duodenal ulcers, erosive gastroesophageal reflux disease (GERD), and pathological hypersecretory conditions like Zollinger-Ellison Syndrome. Treatment durations vary, generally not exceeding 6-12 weeks.
Cimetidine (cimetidine)
(cimetidine)Bionpharma Inc.
Usage: Cimetidine tablets are indicated for the short-term treatment of active duodenal and benign gastric ulcers, maintenance therapy for healed duodenal ulcers, erosive gastroesophageal reflux (GERD), and pathological hypersecretory conditions like Zollinger-Ellison Syndrome. Treatment durations typically do not exceed 8 to 12 weeks.
Cimetidine hydrochloride (cimetidine hydrochloride)
(CIMETIDINE HYDROCHLORIDE)Akorn
Usage: Cimetidine Hydrochloride Oral Solution is indicated for the short-term treatment of active duodenal and benign gastric ulcers, maintenance therapy post-ulcer healing, erosive gastroesophageal reflux disease (GERD), and pathological hypersecretory conditions such as Zollinger-Ellison Syndrome. Treatment duration varies by condition, typically 6-12 weeks.
Esomeprazole magnesium (esomeprazole magnesium)
(Esomeprazole magnesium)CSPC Ouyi Pharmaceutical Co., Ltd.
Usage: Esomeprazole magnesium delayed-release capsules are indicated for the short-term treatment of erosive esophagitis and GERD symptoms, maintenance of healing, reduction of NSAID-associated gastric ulcers in at-risk patients, eradication of H. pylori in duodenal ulcers, and long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison Syndrome.
Esomeprazole magnesium (esomeprazole magnesium)
(Esomeprazole Magnesium)AMTA LABS LIMITED
Usage: Esomeprazole Magnesium Delayed-Release Capsules are indicated for treating erosive esophagitis, GERD symptoms, NSAID-associated gastric ulcers, H. pylori eradication to prevent duodenal ulcers, and long-term management of pathological hypersecretory conditions like Zollinger-Ellison Syndrome. Treatment durations vary from short-term to long-term based on the condition.
Esomeprazole magnesium (esomeprazole magnesium)
(Esomeprazole Magnesium)NuCare Pharmaceuticals,Inc.
Usage: Esomeprazole magnesium delayed-release capsules are indicated for short-term treatment of erosive esophagitis, GERD symptoms, risk reduction of NSAID-associated gastric ulcers, H. pylori eradication to prevent duodenal ulcer recurrence, and long-term management of pathological hypersecretory conditions like Zollinger-Ellison Syndrome.
- ...